AzTrials
AzTrials

Periodontitis, AdultPOLYVIDONENCT03432975

Evaluation of Multiple Subgingival Irrigations.

A study testing Povidone-Iodine 10% and Saline Solution in people with Periodontitis, Adult, run by Cliniques universitaires Saint-Luc- Université Catholique de Louvain at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study will be conducted at the Department of Periodontology, Cliniques universitaires Saint Luc. Patients diagnosed with Generalized Chronic Periodontitis (GChP) based on the current classification of the American Academy of Periodontology will be included. Read more about this study

Who is it for?
Ages 30 years and older
Conditions the study is for
Periodontitis, Adult
What is being tested?
Povidone-Iodine 10% and Saline Solution
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteBelgium
Study dates
18 Dec 2017to 31 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ≥ 30 years of age
  • At least 15 teeth (excluding third molars and teeth with advanced decay indicated for extraction)
  • Any history of periodontal treatment in the previous 6 months
  • No removable prosthesis
  • A minimum of 6 teeth with at least one site each with periodontal probing depth (PPD) and clinical attachment level (CAL) ≥5 mm
  • At least 30% of the sites with PPD and CAL ≥4 mm and bleeding on probing (BOP)

Who cannot join

  • Any sensitivity or allergy to any of the products that will be used in the study
  • Thyroid dysfunction
  • Systemic disease (ASA II or more)
  • Need for antibiotic pre-medication for routine dental therapy
  • Antibiotic therapy in the previous 3 months
  • Pregnancy and breastfeeding
  • Current smokers (more than 5 cigarettes a day)

Trial locations and contacts

1 site in 1 country.

Selena Toma, Parodontologist contact

00322764 ext. 5714

selena.toma@uclouvain.be

Selma Kessler, Dentist contact

00322764 ext. 5714

selma.kessler@uclouvain.be

Belgium1 site, 1 recruiting
  • Cliniques Universitaires Saint-Luc

    Brussels, 1200

    Selena Toma, Parodontologist, 00322764 ext. 5714, selena.toma@uclouvain.be

    Selma Kessler, Dentist, 00322764 ext. 5714, selma.kessler@uclouvain.be

    Recruiting

Other trials in Belgium

About this study

Official title: Evaluation of Multiple Subgingival Irrigations With 10% Povidone Iodine After Scaling and Root Planing : a Randomized Clinical Trial

The study will be conducted at the Department of Periodontology, Cliniques universitaires Saint Luc. Patients diagnosed with Generalized Chronic Periodontitis (GChP) based on the current classification of the American Academy of Periodontology will be included. Detailed medical, periodontal and dental history will be obtained. Those who will fulfill the inclusion/exclusion criteria will be invited to participate in the study.

Read the detailed description

The study will be conducted at the Department of Periodontology, Cliniques universitaires Saint Luc. The patients will be informed in detail of the nature and course of study, and will sign informed consent prior to engagement in the study. Patients diagnosed with GChP based on the current classification of the American Academy of Periodontology will be included. Detailed medical, periodontal and dental history will be obtained. Those who will fulfill the inclusion/exclusion criteria will be invited to participate in the study.

Being tested
Povidone-Iodine 10%, Saline Solution
Medical subject headings
Chronic Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Povidone-Iodine 10%Drug

    The side of the mouth receiving the subgingival irrigations of povidone iodine 10% (test group)

  • Saline SolutionDrug

    The other side of the mouth will be irrigated with a sterile saline solution (control group)

Study groups in NCT03432975
Study groupRoleWhat they receive
Povidone Iodine 10%ExperimentalThe side of the mouth receiving the subgingival irrigations of povidone iodine.
Receives: Drug: Povidone-Iodine 10%
Sterile saline solutionPlacebo comparatorThe other side of the mouth will be irrigated with a sterile saline solution.
Receives: Drug: Saline Solution

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of subjects reaching ≤ 4 mm in periodontal sites with PPD ≥ 5 mm

    The primary objective of this study is to determine the effect of PVI on periodontal probing depth (PPD).

    Measured: up to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Feb 2018
  2. Study start18 Dec 2017
  3. Primary completion31 Aug 2019 (estimated)
  4. Study completion31 Aug 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
20 patients (=40 half-mouth); 20 half-mouth per group
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03432975
Sponsor's protocol ID
2017/06NOV/503
Acronym
POLYVIDONE
Status last verified
Jul 2019
First submitted
8 Feb 2018
Last updated
15 Jul 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Povidone-Iodine 10% and Saline Solution in people with Periodontitis, Adult, run by Cliniques universitaires Saint-Luc- Université Catholique de Louvain at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Selena Toma, Parodontologist (00322764 ext. 5714, selena.toma@uclouvain.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of subjects reaching ≤ 4 mm in periodontal sites with PPD ≥ 5 mm (time frame: up to 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in